Literature DB >> 11439370

NF2 status of meningiomas is associated with tumour localization and histology.

J Kros1, K de Greve, A van Tilborg, W Hop, H Pieterman, C Avezaat, R Lekanne Dit Deprez, E Zwarthoff.   

Abstract

In approximately 60% of sporadic meningiomas, the tumour suppressor gene NF2, located on chromosome 22q, is inactivated. Mutations in the NF2 gene have been specifically reported in transitional and fibrous, but not meningothelial, meningiomas. Since meningothelial meningiomas frequently occur in anterior parts of the skull base, the association between tumour localization, size, histological subtype and NF2 status was investigated in a group of 42 sporadic meningiomas. NF2 status was determined by LOH analysis, karyotyping and FISH. Tumour size and site were evaluated by CT scans and MRIs. A strong correlation between tumour localization in the anterior skull base and intact 22q was revealed (p=0.003). On the other hand, tumour localization at the convexity was associated with disruption of NF2 (p=0.023). Furthermore, an association between chromosome 22 status and histological subtype was observed: abnormalities of chromosome 22q were more frequent in transitional and fibrous meningiomas than in the meningothelial variant (p<0.001). Also, the meningothelial meningiomas were more often located in the anterior skull base (p<0.006). Based on these findings, it is concluded that an alternative histogenesis and genetic pathway is likely to exist for meningiomas arising in the anterior skull base. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11439370     DOI: 10.1002/path.909

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  26 in total

1.  SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas.

Authors:  Julien Boetto; Franck Bielle; Marc Sanson; Matthieu Peyre; Michel Kalamarides
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

2.  Meningioma: a clinicopathological evaluation.

Authors:  Nasrin Samadi; Seyed Ali Ahmadi
Journal:  Malays J Med Sci       Date:  2007-01

Review 3.  Advances in meningioma genetics: novel therapeutic opportunities.

Authors:  Matthias Preusser; Priscilla K Brastianos; Christian Mawrin
Journal:  Nat Rev Neurol       Date:  2018-01-05       Impact factor: 42.937

4.  Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system.

Authors:  Sayaka Yuzawa; Hiroshi Nishihara; Shigeru Yamaguchi; Hiromi Mohri; Lei Wang; Taichi Kimura; Masumi Tsuda; Mishie Tanino; Hiroyuki Kobayashi; Shunsuke Terasaka; Kiyohiro Houkin; Norihiro Sato; Shinya Tanaka
Journal:  Mod Pathol       Date:  2016-04-22       Impact factor: 7.842

5.  Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation.

Authors:  Julien Boetto; Caroline Apra; Franck Bielle; Matthieu Peyre; Michel Kalamarides
Journal:  Oncogene       Date:  2018-05-22       Impact factor: 9.867

6.  Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features.

Authors:  Stéphane Goutagny; Alpha Boubacar Bah; Dominique Henin; Béatrice Parfait; Alexis Bozorg Grayeli; Olivier Sterkers; Michel Kalamarides
Journal:  Neuro Oncol       Date:  2012-06-18       Impact factor: 12.300

7.  Effect of lapatinib on meningioma growth in adults with neurofibromatosis type 2.

Authors:  Diana S Osorio; Jessica Hu; Carole Mitchell; Jeffrey C Allen; Joseph Stanek; Mari Hagiwara; Matthias A Karajannis
Journal:  J Neurooncol       Date:  2018-06-08       Impact factor: 4.130

8.  Multiple meningiomas: differential involvement of the NF2 gene in children and adults.

Authors:  D G R Evans; C Watson; A King; A J Wallace; M E Baser
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

Review 9.  Meningiomas from a developmental perspective: exploring the crossroads between meningeal embryology and tumorigenesis.

Authors:  Julien Boetto; Matthieu Peyre; Michel Kalamarides
Journal:  Acta Neurochir (Wien)       Date:  2020-11-20       Impact factor: 2.216

10.  A novel alternative splicing isoform of NF2 identified in human Schwann cells.

Authors:  Fang Su; Zhengguang Zhou; Wen Su; Zishu Wang; Qiong Wu
Journal:  Oncol Lett       Date:  2016-06-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.